Literature DB >> 342192

5-Fluorocytosine--current status with special references to mode of action and drug resistance.

A Polak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 342192

Source DB:  PubMed          Journal:  Contrib Microbiol Immunol        ISSN: 0301-3081


× No keyword cloud information.
  7 in total

1.  Segregation of 5-fluorocytosine-resistance variants by Candida albicans.

Authors:  W L Whelan; E S Beneke; A L Rogers; D R Soll
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

2.  Molecular mechanisms of resistance to 5-fluorocytosine in laboratory mutants of Candida glabrata.

Authors:  Patrick Vandeputte; Laurent Pineau; Gérald Larcher; Thierry Noel; Daniel Brèthes; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Mycopathologia       Date:  2010-07-09       Impact factor: 2.574

3.  Mechanisms of action of 5-fluorocytosine.

Authors:  A R Waldorf; A Polak
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

Review 4.  Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.

Authors:  Chris Stockmann; Jonathan E Constance; Jessica K Roberts; Jared Olson; Elizabeth H Doby; Krow Ampofo; Justin Stiers; Michael G Spigarelli; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-05       Impact factor: 6.447

Review 5.  Antifungal agents commonly used in the superficial and mucosal candidiasis treatment: mode of action and resistance development.

Authors:  Małgorzata Bondaryk; Wiesław Kurzątkowski; Monika Staniszewska
Journal:  Postepy Dermatol Alergol       Date:  2013-10-30       Impact factor: 1.837

Review 6.  Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy.

Authors:  Ashraf S A El-Sayed; Nabil Z Mohamed; Marwa A Yassin; Mahmoud M Amer; Reyad El-Sharkawy; Nesma El-Sayed; Mostafa G Ali
Journal:  Heliyon       Date:  2022-09-16

Review 7.  Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.

Authors:  Angela Loyse; Françoise Dromer; Jeremy Day; Olivier Lortholary; Thomas S Harrison
Journal:  J Antimicrob Chemother       Date:  2013-06-20       Impact factor: 5.790

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.